Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors.
Until recently, the pathogenesis of type 2 diabetes mellitus (T2DM) has been conceptualized in terms of the predominant defects in insulin secretion and insulin action. It is now recognized that abnormalities in other hormones also contribute to the development of hyperglycemia. For example, the incretin effect, mediated by glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP), is attenuated in T2DM. Intravenous administration of GLP-1 ameliorates hyperglycemia in patients with T2DM, but an extremely short half-life limits its utility as a therapeutic agent. Strategies to leverage the beneficial effects of GLP-1 include GLP-1 receptor agonists or analogs or dipeptidyl peptidase-4 (DPP-4) inhibitors-agents that act by slowing the inactivation of endogenous GLP-1 and GIP. The GLP-1 agonist exenatide has been shown to improve HbA1c and decrease body weight. However, exenatide is limited by its relatively short pharmacologic half-life, various gastrointestinal (GI) side effects, and the development of antibodies. Studies of a long-acting exenatide formulation suggest that it has improved efficacy and also promotes weight loss. Another prospect is liraglutide, a once-daily human GLP-1 analog. In phase 2 studies, liraglutide lowered HbA1c by up to 1.7% and weight by approximately 3 kg, with apparently fewer GI side effects than exenatide. DPP-4 inhibitors such as sitagliptin and vildagliptin result in clinically significant reductions in HbA1c, and are weight neutral with few GI side effects. This review will provide an overview of current and emerging agents that augment the incretin system with a focus on the role of GLP-1 receptor agonists and DPP-4 inhibitors.
Pratley
Richard E
RE
Diabetes and Metabolism Translational Medicine Unit, University of Vermont College of Medicine, Burlington, VT, USA.
Gilbert
Matthew
M
Clin Ther. 2006 Oct;28(10):1556-68
17157112
Curr Med Res Opin. 2008 Jan;24(1):275-86
18053320
J Clin Endocrinol Metab. 1964 Oct;24:1076-82
14228531
Diabet Med. 2007 Sep;24(9):955-61
17509069
Diabetes Obes Metab. 2008 Jul;10(7):593-6
18435773
Diabetes Res Clin Pract. 2007 Apr;76(1):132-8
17223217
Diabet Med. 2008 Feb;25(2):152-6
18201212
Diabetes Care. 2005 May;28(5):1083-91
15855571
Am J Physiol Endocrinol Metab. 2002 Oct;283(4):E745-52
12217892
Horm Metab Res. 2006 Jun;38(6):423-8
16823726
Diabetes Res Clin Pract. 2008 Aug;81(2):161-8
18495285
Diabetes Care. 2004 Nov;27(11):2628-35
15504997
Diabetes Care. 2006 Dec;29(12):2638-43
17130197
Br J Pharmacol. 2003 Sep;140(1):123-32
12967942
Diabetologia. 2007 Feb;50(2):259-67
17160407
Rev Diabet Stud. 2006 Winter;3(4):208-16
17487346
Diabetes Obes Metab. 2007 Mar;9(2):175-85
17300593
Diabetes Obes Metab. 2006 Jul;8(4):419-28
16776749
Diabetes Obes Metab. 2008 Sep;10(10):931-8
18093207
J Clin Endocrinol Metab. 2001 Aug;86(8):3717-23
11502801
Diabetes Care. 2004 Jun;27(6):1335-42
15161785
JAMA. 2007 Jul 11;298(2):194-206
17622601
Diabetologia. 2006 Nov;49(11):2564-71
17001471
Int J Obes Relat Metab Disord. 1999 Mar;23(3):304-11
10193877
Diabetes. 1999 Dec;48(12):2270-6
10580413
Diabetes Obes Metab. 2007 Mar;9(2):194-205
17300595
J Clin Endocrinol Metab. 1996 Jan;81(1):327-32
8550773
J Clin Endocrinol Metab. 2005 Nov;90(11):5991-7
16144950
Diabetologia. 1993 Aug;36(8):741-4
8405741
Endocrinology. 1995 Aug;136(8):3585-96
7628397
Cell Metab. 2006 Mar;3(3):153-65
16517403
Diabetes Care. 2002 Aug;25(8):1398-404
12145241
Ann Intern Med. 2007 Apr 3;146(7):477-85
17404349
Diabetes. 1998 Apr;47(4):640-5
9568698
Diabetes Care. 2005 Aug;28(8):1936-40
16043735
Rev Diabet Stud. 2005 Summer;2(2):61-9
17491680
Metabolism. 2005 Sep;54(9):1168-73
16125528
Diabetes Care. 2004 Aug;27(8):1915-21
15277417
Diabetes Obes Metab. 2006 Jul;8(4):436-47
16776751
Biochem Biophys Res Commun. 2006 Aug 4;346(3):1067-74
16782054
Diabetologia. 2006 Sep;49(9):2049-57
16816950
Am J Physiol Endocrinol Metab. 2004 Dec;287(6):E1209-15
15353407
Diabetes Care. 2008 Jan;31(1):108-13
17909087
Diabetes Obes Metab. 2007 Mar;9(2):166-74
17300592
J Hypertens. 2003 Jun;21(6):1125-35
12777949
Diabetes Obes Metab. 2007 Sep;9(5):733-45
17593236
Regul Pept. 2004 Feb 15;117(2):77-88
14700743
Lancet. 2006 Nov 11;368(9548):1696-705
17098089
Diabetes Care. 2006 Dec;29(12):2632-7
17130196
Diabetes. 2004 Sep;53(9):2492-500
15331566
Int J Clin Pharmacol Ther. 2008 Jun;46(6):273-9
18541123
Am J Physiol. 1997 Nov;273(5):E981-8
9374685
Diabetes. 2003 Feb;52(2):380-6
12540611
Diabetes Care. 2005 Feb;28(2):260-5
15677776
Diabetes Care. 2001 Jan;24(1):89-94
11194248
J Clin Endocrinol Metab. 1986 Aug;63(2):492-8
3522621
Exp Clin Endocrinol Diabetes. 2006 Sep;114(8):417-23
17039422
Diabetes Care. 2005 May;28(5):1092-100
15855572
Expert Opin Investig Drugs. 2007 Feb;16(2):231-7
17243943
Diabetes Care. 2007 Aug;30(8):2032-3
17468345
Diabetologia. 1986 Jan;29(1):46-52
3514343
Int J Biochem Cell Biol. 2006;38(5-6):831-44
16242377
Diabetologia. 2002 Feb;45(2):195-202
11935150
Horm Metab Res. 2006 Dec;38(12):838-44
17163361
N Engl J Med. 1970 Jul 16;283(3):109-15
4912452
Diabetes Care. 2003 Nov;26(11):3080-6
14578243
Diabetologia. 2007 Jun;50(6):1148-55
17387446
N Engl J Med. 1993 Dec 30;329(27):1988-92
8247074
Endocrinology. 2003 Dec;144(12):5149-58
12960095
J Clin Endocrinol Metab. 2003 Jan;88(1):220-4
12519856
Clin Ther. 2007 Jan;29(1):139-53
17379054
J Clin Endocrinol Metab. 2003 Oct;88(10):4897-903
14557471
J Clin Invest. 1999 Sep;104(6):787-94
10491414
J Endocrinol. 1998 Oct;159(1):93-102
9795346
APMIS. 2003 Dec;111(12):1117-24
14678021
Diabetes Care. 2007 Jun;30(6):1608-10
17372153
Diabetologia. 2001 Aug;44(8):929-45
11484070
Diabetes Care. 2007 Jun;30(6):1487-93
17353504
Ann Intern Med. 2005 Oct 18;143(8):559-69
16230722
Diabetes. 1995 Nov;44(11):1249-58
7589820
Rev Diabet Stud. 2007 Fall;4(3):126-33
18084670
Diabetes Care. 2006 Aug;29(8):1963-72
16873813
Diabet Med. 2005 Aug;22(8):1016-23
16026367
Diabetologia. 1997 Feb;40(2):205-11
9049482
Diabetes. 2005 Jan;54(1):146-51
15616022
Diabetes Care. 2007 Aug;30(8):1979-87
17485570
Diab Vasc Dis Res. 2004 May;1(1):40-3
16305055
Proc Natl Acad Sci U S A. 1987 May;84(10):3434-8
3033647
Regul Pept. 2005 Feb 15;125(1-3):173-7
15582729
Diabetes Obes Metab. 2005 Nov;7(6):692-8
16219012
Diabetes. 2004 May;53(5):1187-94
15111485
Biochem Biophys Res Commun. 2005 May 6;330(2):577-84
15796922
J Clin Endocrinol Metab. 2004 Jun;89(6):3055-61
15181098
Diabetes. 2003 Jan;52(1):102-10
12502499